KRAS and rectal cancer: combined MRI radiomics (e.g. Imc1, Coarseness) with KRAS/CEA for rectal cancer liver metastasis prediction (combined AUC 0.842; KRAS odds ratio 8.296), underscoring mutations' independence for model prediction [307].